Received: 7 April 2023
Accepted: 29 June 2023
First Online: 5 July 2023
: Data for ADNI is collected at multiple sites throughout the United States. The local institutional review board for each participating site reviewed and approved the study protocol. All participants provided written informed consent before participating in any study procedures.
: Not applicable.
: MAD, KJM, EHS, REA, and PV report no disclosures relevant to the manuscript. GAM has received research salary support for serving as site principal investigator for clinical trials funded by Eisai Inc., Eli Lilly and Company, and Genentech. These relationships are not related to the content in the manuscript.